P. Levy (Grenoble, France), J. A. Hedner (Gothenburg, Sweden)
Chronic intermittent hypoxia aggravates infarction in isolated rat heart
M. Joyeux-Faure, F. Stanke-Labesque, B. Lefebvre, P. Beguin, D. Godin-Ribuot, C. Ribuot, S. Launois, P. Levy (Grenoble, France)
|  |
Short term hypoxia reduces arterial stiffness in subjects with obstructive sleep apnea
H. Vedam, C. Phillips, D. Barnes, J. Hedner, G. Unger, R. Grunstein (Sydney, Australia; Gothenburg, Sweden)
| |
Effect of adaptive servo-ventilation on plasma endothelin-1 levels in patients with congestive heart failure and Cheyne-Strokes respiration
X. Zhang, K. Yin (Nanjing, China)
| |
Obstructive sleep apnea does not affect circulating hematopoietic precursors
M. R. Bonsignore, O. Marrone, A. Santoro, A. Salvaggio, A. Marfia, M. Gioia, A. Bonanno, L. Riccobono, M. Profita, A. Mirabella, G. Bonsignore, V. Bellia (Palermo, Italy)
| |
Leukocyte-endothelial cell interaction measured by intravital microscopy in a rat model of obstructive sleep apnea (OSA)
M. Nacher, J. Segui, R. Farre, A. Serrano, J. Panes, J. Montserrat (Barcelona, Spain)
| |
Obstructive sleep apnea and risk of systemic hypertension among the middle-aged general population women from 30 to 70 years old. A follow-up study
J. Durán-Cantolla, F. Aizpuru, G. De La Torre, R. Rubio, C. Martinez, J. L. Lobo (Vitoria, Spain)
| |
Catecholamine secretion in obstructive sleep apnoea (OSA)
A. S. Haque, A. G. Davison, T. Tan, K. Metcalfe (Westcliff on Sea, United Kingdom)
| |
Obstructive sleep apnoea does not cause elevated plasma levels of N-terminal pro-brain natriuretic peptide
N. E. El Mokhtari, R. H. Hübner, C. Kohnke, S. Freitag, R. Goeder, T. Rausche, B. Bewig (Kiel, Germany)
| |
Cardiac troponin I levels and relationship with cardiovascular morbidity in patients with obstructive sleep apnea syndrome
N. Demir, O. Kokturk, T. Ulukavak Ciftci, O. Gulbahar, N. Bukan (Ankara, Turkey)
| |
Falls in blood pressure in patients with obstructive sleep apnea syndrome after long-term nasal continuous positive airway pressure treatment
K. Chin, T. Nakamura, K. I. Takahashi, K. Sumi, M. Mishima (Kyoto, Japan)
| |
Blood pressure (BP) changes in sleep disordered breathing (SDB) of various severity
V. Donic, V. Donicova, Z. Tomori, E. Szaboova, S. Gresova (Kosice, Slovakia)
| |
The impact of obstructive sleep apnoea syndrome on endothelial function in patients with moderate and severe hypertension
P. V. Galitsin, A. Y. Litvin, R. A. Galyavi, B. V. Tatyana, P. A. Olga, C. E. Irina (Moscow, Russian Federation)
| |
Effect of continuous positive airway pressure (CPAP) treatment on proangiogenic factors of angiogenesis in obstructive sleep apnea (OSA) patients
A. Arya, M. Stack, K. O‘Sullivan, F. Shanahan, C. P. Bredin (Cork, Wilton, Ireland)
| |
Relative risk of type 2 diabetes mellitus complications is increased in non effectively treated OSA patients
D. Y. Kallistov (Odintsovo, Russian Federation)
| |
Nocturnal oxyhaemoglobin desaturation and coronary artery disease
B. Pencic, M. Dekleva, V. Bakic, N. Kocev, V. Bosnjak, Z. Vasiljevic (Belgrade, Serbia And Montenegro)
| |
Unrecognised hypertension in patients screened for obstructive sleep apnoea
A. R. Proctor, R. Lamb, C. G. Billings, E. D. Moloney (Sheffield, United Kingdom)
| |
Erythrocyte deformability and plasma viscosity in obstructive sleep apnea syndrome
B. Ciftci, S. Firat Guven, N. Dikmenoglu, E. Ileri, N. Seringec (Ankara, Turkey)
| |
Prevalence of sleep apnea in patients with resistant hypertension
P. Lloberes, L. Lozano, J. L. Tovar, D. Untoria, O. Romero, F. Morell, G. Sampol (Barcelona, Spain)
| |
Plasma endothelin-1 (ET-1) levels in obstructive sleep apnea (OSA) patients and effect of continouous positive airway pressure (CPAP) treatment
A. Arya, M. Stack, K. O‘Sullivan, F. Shanahan, C. P. Bredin (Wilton, Cork, Ireland)
| |
BNP or VEGF levels do not predict disease severity in obstructive sleep apnoea syndrome (OSAS)
T. Azher, O. Lyons, S. Zia, B. Lardner, H. Grimes, J. J. Gilmartin (Galway, Ireland)
| |